A Comparative Study on the Accuracy and Efficacy Between Dalton and CINtec® PLUS p16/Ki-67 Dual Stain in Triaging HPV-Positive Women
- PMID: 35141154
- PMCID: PMC8818758
- DOI: 10.3389/fonc.2021.815213
A Comparative Study on the Accuracy and Efficacy Between Dalton and CINtec® PLUS p16/Ki-67 Dual Stain in Triaging HPV-Positive Women
Abstract
Background: CINtec® PLUS p16/Ki-67 dual-stained cytology (DS) is an alternative test to cytology in triaging human papillomavirus (HPV)-positive women. Dalton p16/Ki-67 Dual Stain kit employs the similar immunocytochemical detection and operating procedures with CINtec® PLUS, but its accuracy and efficacy in triaging HPV-positive women need to be evaluated.
Methods: A total of 717 HPV-positive specimens of cervical exfoliated cells were included. Cytology, Dalton, and CINtec® PLUS were subsequently performed, and two DS tests were separately completed in each of the same specimens. The results of two DS tests were head-to-head compared, and their efficacies to identify high-grade cervical intraepithelial neoplasia (CIN) were evaluated, using histopathology of biopsy as the golden standard.
Results: The overall positive rate of two DS tests were 28.31% for Dalton and 33.89% for CINtec® PLUS (p < 0.05); both rose with the increased severity of histopathological and cytological abnormalities. Compared to CINtec® PLUS, the positive rate of Dalton was significantly lower in the normal histopathology group (p < 0.05) and lower, but not significantly, in mild abnormal histopathology and cytology NILM and LSIL groups. Two DS tests showed a good consistency (Kappa value, 0.63; 95% CI, 0.557-0.688), with 100% of consistency in the cytology HSIL group. Inconsistency occurred mainly in the cytology NILM and LSIL groups, with more Dalton negative but CINtec® PLUS positive. Compared to CINtec® PLUS, Dalton showed similar sensitivity (94.59% vs. 91.89%), but significantly higher specificity (75.29% vs. 69.26%, p = 0.013) and accuracy (76.29% vs. 70.43%, p = 0.012), with a larger area under the curve (AUC) of 0.849 (95% CI, 0.800-0.899) for identifying CIN3+. The similar results were observed when identifying CIN2+.
Conclusions: Dalton presents the lower false positive rate and better efficacy in identifying high-grade CIN than CINtec® PLUS, suggesting that Dalton may be superior to CINtec® PLUS and an alternative technique for triaging primary HPV-positive women in cervical cancer screening.
Keywords: cervical cancer; cervical cancer screening; cervical intraepithelial neoplasia; human papillomavirus; p16/Ki-67 dual stain.
Copyright © 2022 Li, Fu, Cheng, Xie and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Comparison of CINtec PLUS cytology and cobas HPV test for triaging Canadian patients with LSIL cytology referred to colposcopy: A two-year prospective study.Cancer Biomark. 2022;34(3):347-358. doi: 10.3233/CBM-210366. Cancer Biomark. 2022. PMID: 35001877 Free PMC article.
-
CINtec PLUS and cobas HPV testing for triaging Canadian women referred to colposcopy with a history of low-grade squamous intraepithelial lesion: Baseline findings.Papillomavirus Res. 2020 Dec;10:100206. doi: 10.1016/j.pvr.2020.100206. Epub 2020 Aug 20. Papillomavirus Res. 2020. PMID: 32828968 Free PMC article.
-
Evaluation of the Performance of CinTec® PLUS in SurePathTM Liquid-Based Cervico-Vaginal Samples.Turk Patoloji Derg. 2021;37(1):32-38. doi: 10.5146/tjpath.2020.01505. Turk Patoloji Derg. 2021. PMID: 33372263 Free PMC article.
-
Diagnostic performance of dual-staining cytology for cervical cancer screening: A systematic literature review.Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:275-280. doi: 10.1016/j.ejogrb.2017.01.009. Epub 2017 Jan 8. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 28086168 Review.
-
Fluorescence In Situ Hybridization (FISH) or Other In Situ Hybridization (ISH) Testing of Uterine Cervical Cells to Predict Precancer and Cancer [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Feb 16. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Feb 16. PMID: 25855849 Free Books & Documents. Review.
Cited by
-
The Immunohistochemical Expression of Epithelial-Mesenchymal Transition Markers in Precancerous Lesions and Cervical Cancer.Int J Mol Sci. 2023 Apr 29;24(9):8063. doi: 10.3390/ijms24098063. Int J Mol Sci. 2023. PMID: 37175770 Free PMC article.
-
The Expression of Testin, Ki-67 and p16 in Cervical Cancer Diagnostics.Curr Issues Mol Biol. 2023 Jan 5;45(1):490-500. doi: 10.3390/cimb45010032. Curr Issues Mol Biol. 2023. PMID: 36661518 Free PMC article.
-
Which is the best management for women with normal cervical cytologic findings despite positivity for non-16/18 high risk human papillomaviruses?Front Public Health. 2022 Nov 9;10:950610. doi: 10.3389/fpubh.2022.950610. eCollection 2022. Front Public Health. 2022. PMID: 36438260 Free PMC article. Review.
-
Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study.Front Oncol. 2022 Jun 7;12:915418. doi: 10.3389/fonc.2022.915418. eCollection 2022. Front Oncol. 2022. PMID: 35747800 Free PMC article.
References
-
- Global Burden of Disease Cancer C. Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, et al. . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol (2019) 5(12):1749–68. doi: 10.1001/jamaoncol.2019.2996 - DOI - PMC - PubMed
-
- Kyrgiou M, Arbyn M, Bergeron C, Bosch FX, Dillner J, Jit M, et al. . Cervical Screening: ESGO-EFC Position Paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). Br J Cancer (2020) 123(4):510–17. doi: 10.1038/s41416-020-0920-9 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
